Target intelligence / Profile preview

Guanylate cyclase activator 1C (GUCA1C)

Target
GUCA1C
Molecular classification
Enzyme regulator, Calcium-binding protein, EF-hand domain containing, Photoreceptor signaling molecule
01

Overview

Guanylate cyclase activator 1C (GUCA1C, also known as guanylyl cyclase-activating protein 3 or GCAP3) is a calcium-binding protein found primarily in the retina, especially in photoreceptor cells[1][2][3][4]. It acts as a calcium sensor and modulates guanylate cyclase activity, thereby regulating levels of cyclic GMP during phototransduction, which is crucial for the visual response to light and the proper recovery of photoreceptors after light exposure[1][3]. GUCA1C is part of the recoverin family and contains EF-hand calcium-binding motifs. Mutations or loss-of-function variants in GUCA1C have been linked to primary congenital glaucoma and retinal neurodegenerative diseases such as cone-rod dystrophy and retinitis pigmentosa[2][3]. The protein fine-tunes cone photoreceptor signaling and may differ functionally from its paralogs GCAP1 and GCAP2, contributing to daylight vision and visual sensitivity[1][3]. No drugs are currently known to directly target GUCA1C, but it is relevant as both a candidate disease gene and a modulator of retinal signaling.

Other names
Guanylyl cyclase-activating protein 3GCAP3GCAP 3
02

Mechanism of action

Allosteric regulation of membrane-bound guanylate cyclases in a calcium-dependent manner

03

Biological functions

Signal transductionRegulation of guanylate cyclase activityModulation of phototransduction pathwayCalcium ion homeostasis
04

Disease associations

Retinal dystrophy (including cone-rod dystrophy)Retinitis pigmentosaPrimary congenital glaucoma
05

Safety considerations

Genetic loss-of-function variants may be associated with retinal neurodegeneration and glaucomatous damage[2]No direct safety data for pharmacological targeting
06

Biomarkers

Possible biomarker for primary congenital glaucoma susceptibility[2]Potential marker for photoreceptor function/dysfunction

Beyond the preview

Go deeper on Guanylate cyclase activator 1C (GUCA1C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase activator 1C (GUCA1C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call